TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

MABQUEST THERAPEUTICS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

MABQUEST THERAPEUTICS

ST13

US500000079435367

Classe

1, 5, 42

Pedido

79435367

Registro

8258456

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

18

Atualização mais recente

19/05/2026

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

1, 5, 42

Data de depósito

29/07/2025

Data de registro

19/05/2026

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

19/05/2026

Última transação

19/05/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

3

Tipo de titular

33

Localização do titular

CH

Examinador

MCDORMAN, ROGER THOMAS

Unidade examinadora

L90

Localização atual

FILE REPOSITORY (FRANCONIA)

Descrição da marca

The mark consists of a trefoil-like figure formed by a canted red equilateral triangle with a red droplet shape extending from each corner thereof, centered above the wording "MABQUEST THERAPEUTICS" in gray type.

Titulares e representantes

Titulares

MabQuest SA

Representantes

Andrea L. Hintz Resonate IP, LLC

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemical, biochemical, biological and biotechnological preparations for use in industry and science other than for medical or veterinary use; chemical, biological and biotechnological preparations, in particular polypeptides and proteins for development or manufacture of reagents for use in industry and science; biological preparations, in particular polypeptides or proteins for use in laboratories and for non-medical diagnosis and analysis in industry and science; chemical and biochemical substances being additives for use in the manufacture of pharmaceuticals; chemical and biochemical substances for use in the manufacture of pharmaceuticals for treating cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; stem cells for research purposes; stem cells for scientific use; cultures of microorganisms other than for medical and veterinary use; cell culture media for scientific and research purposes

Classe 5

Pharmaceutical products for treatment of cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; medicinal preparations for disease treatment, namely, for preventing or treating cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; preparations for medical treatments, in particular preparations based on polypeptides and proteins for treatment of cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; protein complexes for diagnosing cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; synthetic peptides for pharmaceutical use, namely, for treatment of cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; diagnostic agents, preparations and substances for medical purposes; diagnostic substances for medical use; medicinal preparations and substances for preventing and treating cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; pharmaceutical preparations and substances for preventing and treating cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; agents and medicines for therapeutic use, namely, for the treatment of cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; cells for medical use; chemical, biochemical and biological preparations being biological, biochemical, and immunological pharmaceutical preparations for medical use

Classe 42

Analysis and research in laboratories being research laboratory analysis services in the field of chemistry, biochemistry, and molecular biology; scientific research and analysis in the field of chemistry, biochemistry, molecular biology, and immunology; cell culture for scientific research purposes, for others; design and development of medical technologies; research and development in the field of biotechnology; research and development in the field of microorganisms and cells; research and development in the field of diagnostic preparations; pharmaceutical research and development; biochemical research and development; scientific and technological research, particularly in the biochemical, diagnostic or pharmaceutical fields; research and development for the pharmaceutical industry; research and development services in the field of proteins, microorganisms and cells; research and development services in the field of immunology; services of a chemical, biochemical and biological research laboratory; research services, namely, analyses in the field of molecular biology

Publicações

Histórico de despachos e eventos da marca no USPTO.

18 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

19/05/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

19/05/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

31/03/2026

PUBO

PUBLISHED FOR OPPOSITION

31/03/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

25/03/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/03/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/03/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/03/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/03/2026

RFNT

REFUSAL PROCESSED BY IB

12/02/2026

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

24/01/2026

RFRR

REFUSAL PROCESSED BY MPU

24/01/2026

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

15/12/2025

CNRT

NON-FINAL ACTION WRITTEN

14/12/2025

DOCK

ASSIGNED TO EXAMINER

12/12/2025

MAFR

APPLICATION FILING RECEIPT MAILED

27/10/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

27/10/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

23/10/2025

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace MABQUEST THERAPEUTICS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.